Immunomedics resumed with a Buy at B. Riley FBR. B. Riley FBR analyst Harshita Polishetty resumed coverage on Immunomedics with a Buy and $55 price target. https://thefly.com/landingPageNews.php?id=2844953
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.